ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "T-Regulatory Cells"

  • Abstract Number: 1732 • 2014 ACR/ARHP Annual Meeting

    Attenuation of Sclerodermatous Graft Versus Host Disease (sclGVHD) in IL4RA Receptor-Deficient Mice

    Katia Urso1, Kelly Tsang2, Robert Lafyatis3 and Antonios O. Aliprantis2, 1Rheumatology, Brigham and Women's Hospital, Boston, MA, 2Rheumatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 3Rheumatology, Boston University School of Medicine, Boston, MA

    Background/Purpose Scleroderma is a rare autoimmune disease characterized by the accumulation of fibrotic tissue in multiple organs including the skin, gut and lungs. To date,…
  • Abstract Number: 1642 • 2014 ACR/ARHP Annual Meeting

    A Prospective Study of Vitamin D Effects on T Cells Phenotype in Patients with Systemic Lupus Erythematosus Treated with Different Regimens of Supplementation for Two Years

    Silvia Piantoni, Laura Andreoli, Alessandra Zanola, Francesca Dall'Ara, Mirko Scarsi and Angela Tincani, Rheumatology and Clinical Immunology, Spedali Civili and University of Brescia, Brescia, Italy

    Background/Purpose Vitamin D (VD) receptor is constitutively expressed on the membrane of multiple cells, including lymphocytes. Recent studies highlight that VD may have an action…
  • Abstract Number: 1455 • 2014 ACR/ARHP Annual Meeting

    Ex Vivo-Expanded, but Not in Vitro-Induced, Human Regulatory T Cells Are Suitable for Cell Therapy in Rheumatological Autoimmune Diseases Thanks to Stable FOXP3 Demethylation

    Maura Rossetti1, Roberto Spreafico1, Maryam Moshref2, Jorg van Loosdregt3 and Salvatore Albani1, 1SingHealth Translational Immunology and Inflammation Centre, Singapore Health Services Pte Ltd, Duke-NUS Graduate Medical School, Translational Research Unit, Sanford-Burnham Medical Research Institute, Singapore, Singapore, 2Translational Research Unit, Sanford-Burnham Medical Research Institute, La Jolla, CA, 3Translational Research Unit, Sanford-Burnham Medical Research Institute, San Diego, CA

    Background/Purpose: Treg cell therapy is a promising approach for transplant rejection and severe autoimmunity. Unfortunately, sufficient Treg numbers can be obtained only upon in vitroculture. Functional…
  • Abstract Number: 618 • 2014 ACR/ARHP Annual Meeting

    A Gender Bias in Gut Microbiota of SKG Mice Colonized with a Limited Bacterial Consortium Associated with Severity of Spondyloarthritis and Ileitis Triggered By Beta-Glucan

    Linda Rehaume, Olga Zbarskaya, Alicia Kang, Helen Benham, Paraic O Cuiv, Mark Morrison and Ranjeny Thomas, University of Queensland Diamantina Institute, Brisbane, Australia

    Background/Purpose Beta-glucan (curdlan)-treated BALB/c ZAP-70W163C(SKG) mutant mice develop IL-23-dependent spondyloarthritis, and curdlan promotes ileitis in SKG mice housed under specific pathogen-free (SPF) but not germ-free…
  • Abstract Number: 449 • 2014 ACR/ARHP Annual Meeting

    Citrullinated-Vimentin-Specific Regulatory T-Cell Responses Associate with ACPA Positive Individuals with Non-Specific Musculoskeletal Symptoms

    Aamir Aslam1, Jackie L. Nam1, Laura Hunt1, Chadi Rakieh1, Ann W. Morgan2 and Paul Emery1, 1NIHR-Leeds Musculoskeletal Biomedical Research Unit and Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom, 2NIHR-Leeds Musculoskeletal Biomedical Research Unit, University of Leeds, Leeds, United Kingdom

    Background/Purpose: The pathogenesis of RA can be conceptualised by sequential phases that precede the development of synovitis.  Autoimmune antibody responses, including ACPA, can precede clinical…
  • Abstract Number: 335 • 2014 ACR/ARHP Annual Meeting

    Interleukin-33 Suppresses Experimental Arthritis through Promoting Foxp3⁺ Regulatory T-Cells and Type-2 Immune Responses in Mice

    Jerome Biton1, Allan Thiolat1, Sara khaleghparast Athari1, Delphine Lemeiter2, Roxanne Herve1, Patrice Decker1, Jean-Philippe Girard3, Stephane Roga3, André Herbelin4, Anais Levascot4, Marie-Christophe Boissier2 and Natacha Bessis1, 1INSERM UMR 1125, Li2P, University Paris 13, Sorbonne Paris Cité and Rheumatology Department, Avicenne Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Bobigny, France, 2INSERM UMR 1125, Li2P, University Paris 13, Sorbonne Paris Cité, Bobigny, France, 3Centre National de la Recherche Scientifique, Institut de Pharmacologie, dUniversité de Toulouse, Université Paul Sabatier, Institut de Pharmacologie et de Biologie Structurale et de Biologie Structurale, toulouse, France, 4INSERM U1082, Pôle Biologie Santé,, poitiers, France

    Background/Purpose Interleukin (IL)-33 is a new member of the IL-1 family that exerts pleiotropic activities in innate and adaptive immunity. With its receptor ST2, they…
  • Abstract Number: 2908 • 2014 ACR/ARHP Annual Meeting

    Flip Deficiency in Dendritic Cells Promotes Spontaneous Arthritis Mediated By Reduced Treg and Increased Autoreactive CD4+t Cells

    Qiquan Huang1, Harris R. Perlman2, Robert Birkett3, Renee E. Doyle4, Deyu Fang5, G Kenneth.Haines6, William H. Robinson7, Syamal K. Datta8, Hyewon Phee9 and Richard M. Pope10, 1Division of Rheumatology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, 2Northwestern University Feinberg School of Medicine, Chicago, IL, 3Division of Rheumatology, Department od Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, 4Medicine/Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL, 5Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL, 6Mount Sinai Hospital School of Medicine, New York, New York, NY, 7VA Palo Alto Health Care System and Stanford University, Palo Alto, CA, 8Rheumatology Division, Northwestern University Feinberg School of Medicine, Chicago, IL, 9Department of Microbiology-Immunology, Northwestern University Feinberg School of Medicine, Chicago, IL, 10Rheumatology, Northwestern University Feinberg school of Medicine, Chicago, IL

    Background/Purpose Flip (CFLAR) has been identified as a rheumatoid arthritis (RA) risk allele and is important in preventing death receptor mediated apoptosis of dendritic cells…
  • Abstract Number: 2347 • 2014 ACR/ARHP Annual Meeting

    Therapeutic Effect of a Novel Histone Deacetylase 6 Inhibitor, CKD-L, on Collagen Induced Arthritis and Peripheral Blood Mononuclear Cells from Patients with Rheumatoid Arthritis

    Bo Ram Oh1, Hyojin Lim2, Daekwon Bae2, Nina Ha2, Young il Choi2, Hyun Jung Yoo3,4, Jin Kyun Park3, Eun Young Lee5, Eun Bong Lee3 and Yeong Wook Song3,4, 1Division of Rheumatology, Department of Molecular Medicine and Biophamaceutical Sciences, BK 21 plus Graduate School of Convergence Science Technology, Colleage of Medicine, Seoul National University, Seoul, South Korea, 2Department of Pharmacology and Toxicology, CKD Research Institute, CKD Pharmaceutical Company, Seoul, South Korea, 3Division of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea, 4Department of Molecular Medicine and Biophamaceutical Sciences, BK 21 plus Graduate School of Convergence Science Technology, Colleage of Medicine, Seoul National University, Seoul, South Korea, 5Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea

    Background/Purpose Epigenetic regulation plays an important role in inflammatory arthritis, including rheumatoid arthritis (RA). Histone deacetylase inhibitor (HDACi) has been recently reported to have therapeutic…
  • Abstract Number: 2164 • 2014 ACR/ARHP Annual Meeting

    Self-Phospholipids Regulate Inflammation Via Activation of CD1d-Restricted T-cells and Induction of ‘anti-inflammatory’ Myeloid-Derived Suppressor Cells (MDSC)

    Ram Raj Singh1,2,3,4, Cynthia Tran1, Priti Prasad1, Jing Wang5, Dirk Zajonc5 and Ramesh Halder1, 1Autoimmunity and Tolerance Laboratory, Department of Medicine/Rheumatology, UCLA, Los Angeles, CA, 2Interdepartmental Program in Molecular Toxicology, UCLA, Los Angeles, CA, 3Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, CA, 4Department of Pathology and Laboratory Medicine, UCLA, Los Angeles, CA, 5La Jolla Institute of Allergy and Immunology, La Jolla, CA

    Background/Purpose Self-lipids play an increasingly appreciated role in immunity and inflammation. Lipid antigens are presented by CD1d and CD1a-d molecules in mouse and human, respectively,…
  • Abstract Number: 1799 • 2014 ACR/ARHP Annual Meeting

    Elevated Indoleamine-2,3-Dioxygenase (IDO) Activity and Kynurinene-3-Monooxygenase (KMO) Expression in Interferon Positive Primary Sjogrens Syndrome Patients Is Associated with Increased CD25hiFoxP3+ regulatory Tcells: A Skew Towards Neurotoxicity or an Attempt to Rescue?

    Naomi I Maria1, Cornelia G. van Helden-Meeuwsen1, Zana Brkic1, Sandra M.J. Paulissen1,2, Virgil A. Dalm1, Paul L. van Daele1, P. Martin van Hagen1, Sinead M. Gibney1,3, Andrew Harkin3, Hemmo A. Drexhage1, Erik Lubberts1,2 and Marjan A. Versnel1, 1Erasmus Medical Center, Immunology, Rotterdam, Netherlands, 2Erasmus Medical Center, Rheumatology, Rotterdam, Netherlands, 3Trinity College Institute of Neuroscience, Neuropsychopharmacology, Dublin, Ireland

    Background/Purpose: A role for indoleamine-2,3-dioxygenase (IDO) in suppression of effector T-cell function and promotion of regulatory T-cell (Treg) differentiation has been described. IDO - the…
  • Abstract Number: 2696 • 2013 ACR/ARHP Annual Meeting

    Impaired Bacterial Clearance and An Exuberant Inflammatory Response Promote Chlamydia-Induced Reactive Arthritis In SKG Mice

    Athan Baillet1, Linda Rehaume2, Helen Benham2, Connor O'Meara3, Charles Armitage4, Marina Harvie4, Geraldine Brizard5, Jared Velasco2, John V. Forrester6, Mariapia Degli-Esposti5, Kenneth Beagley4 and Ranjeny Thomas2, 1Diamantina Institute, The University of Queensland, Brisbane, Australia, 2University of Queensland Diamantina Institute, Brisbane, Australia, 3Institute of Health & Biomedical Innovation, Biomedical Sciences, Faculty of Health, Queensland University of Technology, Brisbane, Australia, 4Institute of Health & Biomedical Innovation, Brisbane, Australia, 5Lions Eye Institute, Nedlands, Australia, 6Lions Eye Institute, Nedlands, Bahrain

    Background/Purpose:  The sterile inflammatory arthritis associated with spondylitis, uveitis and rash, known as reactive arthritis, commences weeks after certain gastrointestinal or genitourinary infections, including Salmonella…
  • Abstract Number: 2698 • 2013 ACR/ARHP Annual Meeting

    The Treg/Th17 Imbalance Of Patients With Systemic Lupus Erythematosus Were Mediated By Mir-663 Through Down-Regulating TGF-β1 Secretion Of Bone Marrow-Derived Mesenchymal Stem Cells

    Lingyu Geng1, Xia Li1, Xuebing Feng2 and Lingyun Sun3, 1Department of Rheumatology and Immunology, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China, 2Department of Rheumatology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China, 3the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China

    Background/Purpose: Systemic lupus erythematosus (SLE) patients exist an imbalance between CD4+CD25+FoxP3+ T regulatory (Treg) and IL-17-producing cells (Th17). Correction of this Treg/Th17 imbalance may have…
  • Abstract Number: 2711 • 2013 ACR/ARHP Annual Meeting

    Self-Specific Polyclonal CD4 T Cells Enter a FR4hi CD73hi Anergic State To Prevent Immunopathology and Serve As a Reservoir For The Differentiation Of Protective Foxp3+ Tregs

    Lokesh Kalekar1 and Daniel L. Mueller2, 1University of Minnesota Medical School, Minneapolis, MN, 2Medicine/Rheumatic and Autoimmune Diseases, University of Minnesota Medical School, Minneapolis, MN

    Background/Purpose: Clonal anergy has been proposed as a mechanism to allow for peripheral recognition of self antigens, without the consequence of immunopathology. Model systems have…
  • Abstract Number: 2713 • 2013 ACR/ARHP Annual Meeting

    IL-21 Inhibited Follicular Regulatory T Cells To Promote Autoreactive Germinal Center Development In Autoimmune BXD2 Mice

    Yanna Ding1, Hui-Chen Hsu2,3, Jun Li4, PingAr Yang4, Qi Wu4, Allan J. Zajac5 and John D. Mountz3,6, 1University of Alabama at Birmingham, Birmingham, AL, 2Department of Medicine, Clinical Immunology & Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 3Birmingham VA Medical Center, Birmingham, AL, 4Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, 5Microbiology, University of Alabama at Birmingham, Birmingham, AL, 6Dept of Med/Rheumatology Div, University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: Follicular T helper (Tfh) cells have been correlated with germinal center (GC) formation, autoantibody production and disease severity in human systemic lupus erythematosus (SLE).…
  • Abstract Number: 2215 • 2013 ACR/ARHP Annual Meeting

    Apoptotic Cell-Based Therapy To Treat Collagen-Induced Experimental Arthritis. Rationale For The Use Of Apoptotic Cells In The Treatment Of Rheumatoid Arthritis

    Sylvain Perruche1, Amandine Clauzon1, Francis Bonnefoy1, Eric Toussirot2 and Philippe Saas3, 1UMR1098 INSERM, EFS Bourgogne Franche Comté, Besançon, France, 2Université de Franche Comté , CHRU, CIC Biotherapy 506 and Rheumatology and EA 4266 Pathogens and Inflammation, Besançon, France, 3Etablisement Français du Sang ; Université de Franche Comté, INSERM UMR1098, Besançon, France

    Background/Purpose: Most of the currently available biological agents used in the treatment of rheumatoid arthritis (RA) target a cellular or soluble factor involved in the…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology